X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2270) 2270
Publication (193) 193
Book Review (46) 46
Newsletter (25) 25
Magazine Article (11) 11
Book Chapter (5) 5
Trade Publication Article (2) 2
Data Set (1) 1
Dissertation (1) 1
Newspaper Article (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1633) 1633
sertraline (1600) 1600
male (1168) 1168
female (1090) 1090
psychiatry (1048) 1048
adult (846) 846
index medicus (800) 800
pharmacology & pharmacy (677) 677
middle aged (660) 660
treatment outcome (576) 576
antidepressants (566) 566
serotonin uptake inhibitors - therapeutic use (552) 552
fluoxetine (542) 542
sertraline - therapeutic use (513) 513
depression (456) 456
double-blind (454) 454
paroxetine (381) 381
neurosciences (378) 378
aged (369) 369
double-blind method (363) 363
serotonin uptake inhibitors - administration & dosage (363) 363
antidepressive agents - therapeutic use (361) 361
sertraline - administration & dosage (354) 354
serotonin uptake inhibitors - adverse effects (335) 335
drug therapy (328) 328
adolescent (327) 327
animals (305) 305
clinical neurology (298) 298
depressive disorder - drug therapy (295) 295
dose-response relationship, drug (293) 293
serotonin (281) 281
drug administration schedule (270) 270
sertraline - adverse effects (257) 257
major depression (256) 256
depressive disorder, major - drug therapy (253) 253
serotonin reuptake inhibitors (248) 248
dosage and administration (246) 246
efficacy (238) 238
serotonin uptake inhibitors - pharmacology (227) 227
psychiatric status rating scales (213) 213
sertraline - pharmacology (212) 212
antidepressive agents - administration & dosage (208) 208
depression, mental (206) 206
serotonin uptake inhibitors (204) 204
care and treatment (194) 194
placebo (194) 194
research (191) 191
1-naphthylamine - analogs & derivatives (187) 187
rats (184) 184
citalopram (176) 176
depression - drug therapy (175) 175
antidepressive agents - adverse effects (174) 174
drug therapy, combination (162) 162
psychology, clinical (162) 162
major depressive disorder (160) 160
fluvoxamine (159) 159
mental depression (158) 158
pharmacotherapy (153) 153
child (150) 150
analysis (148) 148
anxiety (144) 144
medicine & public health (141) 141
clinical trials (140) 140
young adult (140) 140
antidepressant (134) 134
time factors (134) 134
article (133) 133
health aspects (131) 131
severity of illness index (131) 131
drug interactions (129) 129
drugs (129) 129
placebo-controlled trial (129) 129
comorbidity (127) 127
risk factors (123) 123
depressive disorder - psychology (115) 115
obsessive-compulsive disorder (115) 115
venlafaxine (114) 114
children (109) 109
paroxetine - therapeutic use (109) 109
symptoms (109) 109
pharmacology (107) 107
antidepressive agents - pharmacology (106) 106
pharmacokinetics (104) 104
placebos (104) 104
antidepressive agents, second-generation - therapeutic use (102) 102
fluoxetine - therapeutic use (102) 102
citalopram - therapeutic use (98) 98
brain (97) 97
psychology (97) 97
ptsd (97) 97
medicine, general & internal (96) 96
disorder (95) 95
sertraline treatment (95) 95
combined modality therapy (94) 94
selective serotonin reuptake inhibitors (94) 94
mice (92) 92
pediatrics (92) 92
follow-up studies (91) 91
prevalence (91) 91
antidepressive agents, second-generation - adverse effects (90) 90
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2255) 2255
Spanish (15) 15
French (12) 12
Japanese (11) 11
Russian (11) 11
German (5) 5
Chinese (3) 3
Turkish (3) 3
Danish (2) 2
Polish (2) 2
Swedish (2) 2
Dutch (1) 1
Hungarian (1) 1
Korean (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2016, Volume 388, Issue 10047, pp. 881 - 890
Summary Background Major depressive disorder is one of the most common mental disorders in children and adolescents. However, whether to use pharmacological... 
Internal Medicine | TRIALS | MEDICINE, GENERAL & INTERNAL | ACCEPTABILITY | MENTAL-HEALTH-CARE | TRENDS | GUIDELINES | Mianserin - adverse effects | Triazoles - administration & dosage | Triazoles - adverse effects | Humans | Citalopram - adverse effects | Sertraline - adverse effects | Venlafaxine Hydrochloride - adverse effects | Imipramine - administration & dosage | Paroxetine - adverse effects | Mianserin - analogs & derivatives | Paroxetine - administration & dosage | Desipramine - adverse effects | Nortriptyline - administration & dosage | Nortriptyline - adverse effects | Mianserin - administration & dosage | Child | Fluoxetine - adverse effects | Depressive Disorder, Major - drug therapy | Clomipramine - administration & dosage | Duloxetine Hydrochloride - adverse effects | Double-Blind Method | Drug Administration Schedule | Treatment Outcome | Clomipramine - adverse effects | Evidence-Based Medicine | Desipramine - administration & dosage | Randomized Controlled Trials as Topic | Venlafaxine Hydrochloride - administration & dosage | Citalopram - administration & dosage | Confounding Factors (Epidemiology) | Sertraline - administration & dosage | Adolescent | Amitriptyline - adverse effects | Bayes Theorem | Fluoxetine - administration & dosage | Duloxetine Hydrochloride - administration & dosage | Antidepressive Agents - administration & dosage | Antidepressive Agents - adverse effects | Research Design | Amitriptyline - administration & dosage | Imipramine - adverse effects | Psychological aspects | Medical colleges | Neurosciences | Drugs and youth | Rankings | Comparative analysis | Child psychopathology | Major depressive disorder | Antidepressants, Tricyclic | Pediatric pharmacology | Mental illness | Studies | Teenagers | Mental depression | Antidepressants | Meta-analysis | Children & youth
Journal Article
American Journal of Psychiatry, ISSN 0002-953X, 03/2013, Volume 170, Issue 3, pp. 256 - 262
Journal Article
CMAJ, ISSN 0820-3946, 11/2011, Volume 183, Issue 16, pp. 1835 - 1843
Background: Patients prescribed antiplatelet treatment to prevent recurrent acute myocardial infarction are often also given a selective serotonin reuptake... 
DEPRESSION | ESOMEPRAZOLE | MEDICINE, GENERAL & INTERNAL | ANTIDEPRESSANTS | CLOPIDOGREL | EVENTS | PROGNOSIS | DRUGS | ELDERLY-PATIENTS | ASPIRIN | Age Factors | Anemia - epidemiology | Angioplasty | Humans | Middle Aged | Citalopram - adverse effects | Male | Risk | Secondary Prevention | Sertraline - adverse effects | Peptic Ulcer - epidemiology | Adrenal Cortex Hormones - therapeutic use | Renal Insufficiency - epidemiology | Aspirin - administration & dosage | Paroxetine - adverse effects | Paroxetine - administration & dosage | Fluvoxamine - administration & dosage | Canada - epidemiology | Aspirin - adverse effects | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - adverse effects | Ticlopidine - administration & dosage | Female | Retrospective Studies | Drug Therapy, Combination | Heart Failure - epidemiology | Fluoxetine - adverse effects | Platelet Aggregation Inhibitors - adverse effects | Hypoglycemic Agents - therapeutic use | Hemorrhage - epidemiology | Risk Factors | Serotonin Uptake Inhibitors - adverse effects | Anticoagulants - therapeutic use | Antihypertensive Agents - therapeutic use | Fluvoxamine - adverse effects | Ticlopidine - analogs & derivatives | Citalopram - administration & dosage | Sertraline - administration & dosage | Serotonin Uptake Inhibitors - administration & dosage | Fluoxetine - administration & dosage | Sex Factors | Aged | Myocardial Infarction - prevention & control | Hemorrhage - chemically induced | Neoplasms - epidemiology | Cohort Studies | Aggregation | Complications and side effects | Blood platelets | Patient outcomes | Serotonin uptake inhibitors | Dosage and administration | Drug therapy | Hemorrhage | Heart attack | Risk factors | Studies | Side effects | Heart attacks | Inhibitor drugs | Research
Journal Article
Journal Article
Journal Article
Trials, ISSN 1745-6215, 01/2019, Volume 20, Issue 1, pp. 34 - 11
BackgroundMajor depressive disorder (MDD) is a common psychiatric disorder. With systematic antidepressant treatment, 50-75% of patients have a treatment... 
Phosphocreatine | Fluoxetine | Randomized controlled trial | Adenosine triphosphate | Fast-acting antidepressant | Major depressive disorder | MEDICINE, RESEARCH & EXPERIMENTAL | CREATINE MONOHYDRATE AUGMENTATION | ENERGY | EFFICACY | SERTRALINE | PREFRONTAL CORTEX | DAMAGE | WOMEN | METABOLISM | HYPOTHESIS | COENZYME-Q10 | Adenosine Triphosphate - administration & dosage | Antidepressive Agents, Second-Generation - adverse effects | Humans | Middle Aged | Male | Antidepressive Agents, Second-Generation - administration & dosage | Feasibility Studies | Young Adult | Time Factors | China | Adult | Female | Drug Therapy, Combination | Fluoxetine - adverse effects | Adenosine Triphosphate - adverse effects | Depressive Disorder, Major - drug therapy | Affect - drug effects | Patient Health Questionnaire | Double-Blind Method | Drug Administration Schedule | Administration, Oral | Serotonin Uptake Inhibitors - adverse effects | Treatment Outcome | Phosphocreatine - adverse effects | Phosphocreatine - administration & dosage | Randomized Controlled Trials as Topic | Depressive Disorder, Major - psychology | Administration, Intravenous | Pilot Projects | Serotonin Uptake Inhibitors - administration & dosage | Adolescent | Fluoxetine - administration & dosage | Aged | Depressive Disorder, Major - diagnosis | Usage | Physiological aspects | Dosage and administration | Drug therapy, Combination | Drug therapy | Health aspects | Testing
Journal Article
Molecular Psychiatry, ISSN 1359-4184, 03/2016, Volume 21, Issue 3, pp. 328 - 338
Journal Article
Journal Article
Journal Article